These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 24250423)
1. Expression of Drug Pump Protein MRP2 in Lipopolysaccharide-Treated Rats and its Impact on the Disposition of Acetaminophen. Hassany M; Hassanzadeh Khayat M; Behravan J; Kasaeeian J Iran J Pharm Res; 2011; 10(4):855-9. PubMed ID: 24250423 [TBL] [Abstract][Full Text] [Related]
2. Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein. Ghanem CI; Gómez PC; Arana MC; Perassolo M; Ruiz ML; Villanueva SS; Ochoa EJ; Catania VA; Bengochea LA; Mottino AD Biochem Pharmacol; 2004 Aug; 68(4):791-8. PubMed ID: 15276087 [TBL] [Abstract][Full Text] [Related]
3. Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease. Lickteig AJ; Fisher CD; Augustine LM; Aleksunes LM; Besselsen DG; Slitt AL; Manautou JE; Cherrington NJ Drug Metab Dispos; 2007 Oct; 35(10):1970-8. PubMed ID: 17640958 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats. Hoffmann K; Löscher W Epilepsia; 2007 Apr; 48(4):631-45. PubMed ID: 17437408 [TBL] [Abstract][Full Text] [Related]
5. Effects of High-cholesterol Diet on Pravastatin Disposition in the Perfused Rat Liver. Kawase A; Handa A; Iwaki M Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):519-526. PubMed ID: 27511381 [TBL] [Abstract][Full Text] [Related]
6. An experimental approach to evaluate the impact of impaired transport function on hepatobiliary drug disposition using Mrp2-deficient TR- rat sandwich-cultured hepatocytes in combination with Bcrp knockdown. Yang K; Pfeifer ND; Hardwick RN; Yue W; Stewart PW; Brouwer KL Mol Pharm; 2014 Mar; 11(3):766-75. PubMed ID: 24410402 [TBL] [Abstract][Full Text] [Related]
7. Taurine supplementation induces multidrug resistance protein 2 and bile salt export pump expression in rats and prevents endotoxin-induced cholestasis. Mühlfeld A; Kubitz R; Dransfeld O; Häussinger D; Wettstein M Arch Biochem Biophys; 2003 May; 413(1):32-40. PubMed ID: 12706339 [TBL] [Abstract][Full Text] [Related]
8. Spironolactone ameliorates lipopolysaccharide-induced cholestasis in rats by improving Mrp2 function: Role of transcriptional and post-transcriptional mechanisms. Razori MV; Martín PL; Maidagan PM; Barosso IR; Ciriaci N; Andermatten RB; Sánchez Pozzi EJ; Basiglio CL; Ruiz ML; Roma MG Life Sci; 2020 Oct; 259():118352. PubMed ID: 32860804 [TBL] [Abstract][Full Text] [Related]
10. Effects of Red Ginseng Extract on the Pharmacokinetics and Elimination of Methotrexate via Mrp2 Regulation. Lee S; Kwon M; Choi MK; Song IS Molecules; 2018 Nov; 23(11):. PubMed ID: 30424502 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of xenobiotic detoxification system mediated by efflux transporters]. Suzuki H Yakugaku Zasshi; 1999 Nov; 119(11):822-34. PubMed ID: 10590710 [TBL] [Abstract][Full Text] [Related]
13. Implication of hepatic transporters (MDR1 and MRP2) in inflammation-associated idiosyncratic drug-induced hepatotoxicity investigated by microvolume cytometry. Saab L; Peluso J; Muller CD; Ubeaud-Sequier G Cytometry A; 2013 Apr; 83(4):403-8. PubMed ID: 23401306 [TBL] [Abstract][Full Text] [Related]
14. LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Elferink MG; Olinga P; Draaisma AL; Merema MT; Faber KN; Slooff MJ; Meijer DK; Groothuis GM Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1008-16. PubMed ID: 15205115 [TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Cherrington NJ; Slitt AL; Li N; Klaassen CD Drug Metab Dispos; 2004 Jul; 32(7):734-41. PubMed ID: 15205389 [TBL] [Abstract][Full Text] [Related]
16. Suppression of efflux transporters in the intestines of endotoxin-treated rats. Tomita M; Takizawa Y; Kanbayashi A; Murata H; Tanaka A; Nakaike M; Hatanaka M; Kai T; Hayashi M Int J Pharm; 2012 May; 428(1-2):33-8. PubMed ID: 22387888 [TBL] [Abstract][Full Text] [Related]
17. Role of rat multidrug resistance protein 2 in plasma and biliary disposition of dibromosulfophthalein after microsomal enzyme induction. Johnson DR; Klaassen CD Toxicol Appl Pharmacol; 2002 Apr; 180(1):56-63. PubMed ID: 11922777 [TBL] [Abstract][Full Text] [Related]
18. Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans. Oswald S; Haenisch S; Fricke C; Sudhop T; Remmler C; Giessmann T; Jedlitschky G; Adam U; Dazert E; Warzok R; Wacke W; Cascorbi I; Kroemer HK; Weitschies W; von Bergmann K; Siegmund W Clin Pharmacol Ther; 2006 Mar; 79(3):206-17. PubMed ID: 16513445 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Goralski KB; Hartmann G; Piquette-Miller M; Renton KW Br J Pharmacol; 2003 May; 139(1):35-48. PubMed ID: 12746221 [TBL] [Abstract][Full Text] [Related]
20. Saikosaponin b2 enhances the hepatotargeting effect of anticancer drugs through inhibition of multidrug resistance-associated drug transporters. Zhao Y; Feng L; Liu L; Zhao R Life Sci; 2019 Aug; 231():116557. PubMed ID: 31194994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]